ArticleSurgical endoscopy2026
Surgeon-controlled robotic CUSA technique for liver parenchymal transection.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic liver resection provides a stable and magnified operative field; however, parenchymal transection often relies on skilled bedside assistance, limiting console surgeon autonomy and reproducibility. We developed a surgeon-controlled robotic CUSA technique that allows the console surgeon to perform parenchymal transection using a simple, handmade attachment. This study aimed to describe the technique and evaluate its perioperative outcomes compared with the clamp-crush method.
methodsPatients who underwent robotic liver resection at our institution between October 2022 and December 2025 were retrospectively reviewed. Parenchymal transection was performed using the clamp-crush technique in the early period and transitioned to the surgeon-controlled robotic CUSA technique in the later period. All procedures were performed by two board-certified expert hepatobiliary surgeons using the da Vinci Xi or hinotori robotic systems. Perioperative outcomes were compared between groups. Continuous variables were analyzed using the Mann-Whitney U-test and categorical variables using the χ
resultsA total of 44 patients were included: 19 in the clamp-crush group and 25 in the CUSA group. There were no significant differences between groups in sex, diagnosis, background liver function, or tumor location. Major or segmental resections tended to be more frequent in the CUSA group; however, the difference was not statistically significant. Operation time, liver resection time, estimated blood loss, conversion to open or laparoscopic surgery, postoperative complications, length of hospital stay, and R0 resection rates were not significantly different between groups.
conclusionThe surgeon-controlled robotic CUSA technique demonstrated perioperative outcomes comparable to those of the clamp-crush method while enabling surgeon-controlled parenchymal transection. This approach may serve as a valuable technical option for selected robotic liver resections in experienced centers and provides a platform for future comparative and educational studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.